Bill cuts FDA fees for small U.S. device makers
H.R. 9791 — NO FEES Act of 2026 · Filed by Scott Perry (R-PA) · Introduced Jul 20, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
The bill changes what counts as a small business for FDA device fees. Small businesses now mean companies with fewer than 20 full-time workers. These small U.S. companies get free FDA registration for three years. Then they pay half price for two more years. Foreign-owned companies cannot get this break. Foreign device makers must pay eight times the normal fee. The FDA cannot look at past unpaid fees when deciding who gets the waiver.
Who it affects
Small U.S. medical device makers and diagnostic makers gain lower costs. Foreign device makers pay much higher fees. Patients and hospitals may pay more if foreign device costs go up.
One thing to notice
The bill stops courts from reviewing FDA waiver denials. Small companies cannot challenge the FDA in court if denied.
From the analysis of the bill text, linked under Primary records below.
Where it stands
- Jul 20, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jul 20, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
2 groups reported lobbying about this bill. They filed 2 reports from Jun 2026 to Jun 2026.
Those reports show $40,000 in lobbying spending. Each report lists about 2 bills. So that money was not all for this bill.
More groups named this bill than 41% of bills with any report.
Scott Perry, who sponsored the bill, received $651,494 from PACs for the 2026 election.
- Florida Memorial University — $20,000 in 1 report
- Virginia Union University — $20,000 in 1 report
Lobbying is legal. These reports show who lobbied about this bill, not what changed.
Words to know
- waiver — Permission to skip a rule or fee that normally applies.
- FDA — The Food and Drug Administration, the government agency that approves medicines and medical devices.
- small business — A company with fewer than 20 full-time workers under this bill.
- registration — The process of telling the FDA about a medical device before selling it.
- lobbying — Trying to influence lawmakers about a bill. Companies and groups pay people to do this.
- PACs — Groups that collect money and give it to candidates for office.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (3,818 characters) on Aug 12, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 14,707 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 17, 2026 · page rendered 2026-09-23.
“Bill cuts FDA fees for small U.S. device makers” QuorumCivic. https://share.quorumcivic.app/bill/119/hr9791/simple Report an error